Altrova Health Inc. (CSE:ROVA)
Canada flag Canada · Delayed Price · Currency is CAD
0.0500
0.00 (0.00%)
At close: Jun 12, 2026

John Keells Holdings Income Statement

Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2023
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Apr '23
0.140.03---
Cost of Revenue
0.10.05---
Gross Profit
0.04-0.02---
Selling, General & Admin
1.2212.32.23.47
Operating Expenses
2.041.374.332.23.47
Operating Income
-1.99-1.39-4.33-2.2-3.47
Interest Expense
-----0
Interest & Investment Income
--00.01-
Currency Exchange Gain (Loss)
0-0-00.01-
Other Non Operating Income (Expenses)
-0.19-0.22-0.35-7.28-
EBT Excluding Unusual Items
-2.18-1.61-4.69-9.46-3.47
Merger & Restructuring Charges
-0.24-0.24---
Impairment of Goodwill
-2.49-2.49---
Gain (Loss) on Sale of Investments
-0.03-0.03-0.34--
Gain (Loss) on Sale of Assets
-0.07-0.07---
Other Unusual Items
0.150.15---
Pretax Income
-4.84-4.28-5.02-9.46-3.47
Net Income
-4.84-4.28-5.02-9.46-3.47
Net Income to Common
-4.84-4.28-5.02-9.46-3.47
Shares Outstanding (Basic)
1841397531-
Shares Outstanding (Diluted)
1841397531-
Shares Change (YoY)
101.01%84.69%141.97%--
EPS (Basic)
-0.03-0.03-0.07-0.30-
EPS (Diluted)
-0.03-0.03-0.07-0.30-
Free Cash Flow
-0.77-0.96-3.06-1.390.38
Free Cash Flow Per Share
-0.00-0.01-0.04-0.04-
Gross Margin
31.71%-60.55%---
Operating Margin
-1409.59%-4717.12%---
Profit Margin
-3424.24%-14522.72%---
Free Cash Flow Margin
-545.45%-3255.27%---
EBITDA
-1.96-1.39-4.33--
D&A For EBITDA
0.0300--
EBIT
-1.99-1.39-4.33-2.2-3.47